Akt-mediated foxo1 inhibition is required for liver regeneration

Hepatology

Volumn 63, Issue 5, 2016, Pages 1660-1674

  Pauta, Montse ^a,b   Rotllan, Noemi ^b,c   Fernández Hernando, Ana ^b   Langhi, Cedric ^d   Ribera, Jordi ^a   Lu, Mingjian ^e,g   Boix, Loreto ^f   Bruix, Jordi ^f   Jimenez, Wladimiro ^a,f   Suárez, Yajaira ^b,c   Ford, David A ^d   Baldán, Angel ^d   Birnbaum, Morris J ^e   Morales Ruiz, Manuel ^a,f   Fernández Hernando, Carlos ^b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF BARCELONA   (Spain)

^g Lilly China Research and Development Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FAT DROPLET; GROWTH FACTOR; PROTEIN KINASE B; PROTEIN KINASE B BETA; TRANSCRIPTION FACTOR FKHR; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; AKT1 PROTEIN, MOUSE; AKT2 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; PDPK1 PROTEIN, MOUSE;

AKT1 GENE; AKT2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FOXO1 GENE; GENE; GENE DELETION; GLYCOGEN SYNTHESIS; INTRACELLULAR SIGNALING; LIVER FUNCTION; LIVER HYPERTROPHY; LIVER REGENERATION; MALE; MORTALITY; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; ANIMAL; ANTAGONISTS AND INHIBITORS; HYPERPLASIA; LIPID METABOLISM; LIVER CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; ANIMALS; FORKHEAD BOX PROTEIN O1; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTES; HYPERPLASIA; LIPID METABOLISM; LIVER REGENERATION; MALE; MICE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84951765778     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28286     Document Type: Article

References (59)

1. Fasusto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43(Suppl. 1):S45-S53.
2. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997;276:60-66.
3. Higgins GM, Anderson RM. Experimental pathology of liver resection. Arch Pathol 1931;12:186-197.
4. Bismuth H, Houssin D, Ornowski J, Meriggi F. Liver resections in cirrhotic patients: a Western experience. World J Surg 1986;10:311-317.
5. Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, et al. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2015;21:79-88.
6. Bruix J, Gores G, Mazzaferro V. Authors' response to the letter: Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours or portal hypertension by Zhong et al. Gut 2015;64:522.
7. Wong TC, Lo CM. Resection strategies for hepatocellular carcinoma. Semin Liver Dis 2013;33:273-281.
8. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
9. Michalopoulos GK. Liver regeneration. J Cell Physiol 2007;213:286-300.
10. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007;129:1261-1274.
11. Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 2003;278:32124-32131.
12. Di Lorenzo A, Fernandez-Hernando C, Cirino G, Sessa WC. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc Natl Acad Sci USA 2009;106:14552-14557.
13. Lee MY, Luciano AK, Ackah E, Rodriguez-Vita J, Bancroft TA, Eichmann A, et al. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc Natl Acad Sci USA 2014;111:12865-12870.
14. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001;292:1728-1731.
15. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, et al. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 2005;25:1869-1878.
16. Hong F, Nguyen VA, Shen X, Kunos G, Gao B. Rapid activation of protein kinase B/Akt has a key role in antiapoptotic signaling during liver regeneration. Biochem Biophys Res Commun 2000;279:974-979.
17. Liu HX, Fang Y, Hu Y, Gonzalez FJ, Fang J, Wan YJ. PPARbeta regulates liver regeneration by modulating Akt and E2f signaling. PLoS One 2013;8:e65644.
18. Marshall KM, He S, Zhong Z, Atkinson C, Tomlinson S. Dissecting the complement pathway in hepatic injury and regeneration with a novel protective strategy. J Exp Med 2014;211:1793-1805.
19. Haga S, Ozaki M, Inoue H, Okamoto Y, Ogawa W, Takeda K, et al. The survival pathways phosphatidylinositol-3 kinase (PI3-K)/phosphoinositide-dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation. Hepatology 2009;49:204-214.
20. Jackson LN, Larson SD, Silva SR, Rychahou PG, Chen LA, Qiu S, et al. PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2008;294:G1401-G1410.
21. Mullany LK, Nelsen CJ, Hanse EA, Goggin MM, Anttila CK, Peterson M, et al. Akt-mediated liver growth promotes induction of cyclin E through a novel translational mechanism and a p21-mediated cell cycle arrest. J Biol Chem 2007;282:21244-21252.
22. Wan M, Easton RM, Gleason CE, Monks BR, Ueki K, Kahn CR, et al. Loss of Akt1 in mice increases energy expenditure and protects against diet-induced obesity. Mol Cell Biol 2012;32:96-106.
23. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 2009;10:405-418.
24. Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab 2007;6:208-216.
25. Lu M, Wan M, Leavens KF, Chu Q, Monks BR, Fernandez S, et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat Med 2012;18:388-395.
26. Gross DN, Wan M, Birnbaum MJ. The role of FOXO in the regulation of metabolism. Curr Diab Rep 2009;9:208-214.
27. -/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids. J Hepatol 2013;59:731-737.
28. Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol 2006;7:373-378.
29. Garcia-Arcos I, Gonzalez-Kother P, Aspichueta P, Rueda Y, Ochoa B, Fresnedo O. Lipid analysis reveals quiescent and regenerating liver-specific populations of lipid droplets. Lipids 2010;45:1101-1108.
30. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-1101.
31. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. Protein kinase B kinases that mediate phosphatidylinositol 3, 4, 5-trisphosphate-dependent activation of protein kinase B. Science 1998;279:710-714.
32. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999;399:597-601.
33. Lee MJ, Thangada S, Paik JH, Sapkota GP, Ancellin N, Chae SS, et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol Cell 2001;8:693-704.
34. Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N, et al. Akt activation protects rat liver from ischemia/reperfusion injury. J Surg Res 2004;121:159-170.
35. Morales-Ruiz M, Cejudo-Martin P, Fernandez-Varo G, Tugues S, Ros J, Angeli P, et al. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 2003;125:522-531.
36. Morales-Ruiz M, Fondevila C, Munoz-Luque J, Tugues S, Rodriguez-Laiz G, Cejudo-Martin P, et al. Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantation. Am J Transplant 2007;7:769-778.
37. Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 2005;11:952-958.
38. Ping C, Lin Z, Jiming D, Jin Z, Ying L, Shigang D, et al. The phosphoinositide 3-kinase/Akt-signal pathway mediates proliferation and secretory function of hepatic sinusoidal endothelial cells in rats after partial hepatectomy. Biochem Biophys Res Commun 2006;342:887-893.
39. Palmes D, Zibert A, Budny T, Bahde R, Minin E, Kebschull L, et al. Impact of rapamycin on liver regeneration. Virchows Arch 2008;452:545-557.
40. Yan-nan B, Zhao-yan Y, Li-xi L, Jiang Y, Qing-jie X, Yong Z. MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN. Biochem Biophys Res Commun 2014;443:802-807.
41. Mackay HJ, Twelves CJ. Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 2007;7:554-562.
42. Mora A, Komander D, van Aalten DM, Alessi DR. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 2004;15:161-170.
43. Dong LQ, Liu F. PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab 2005;289:E187-E196.
44. Liu P, Begley M, Michowski W, Inuzuka H, Ginzberg M, Gao D, et al. Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus. Nature 2014;508:541-545.
45. Chen R, Kim O, Yang J, Sato K, Eisenmann KM, McCarthy J, et al. Regulation of Akt/PKB activation by tyrosine phosphorylation. J Biol Chem 2001;276:31858-31862.
46. Mahajan K, Coppola D, Challa S, Fang B, Chen YA, Zhu W, et al. Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One 2010;5:e9646.
47. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 2001;15:2203-2208.
48. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 2001;276:38349-38352.
49. Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol 2003;171:1623-1629.
50. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868.
51. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999;398:630-634.
52. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004;117:421-426.
53. 1 cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000;12:676-684.
54. Schmidt M, Fernandez de Mattos S, van der Horst A, Klompmaker R, Kops GJ, Lam EW, et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 2002;22:7842-7852.
55. Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S, et al. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 2008;456:269-273.
56. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003;423:550-555.
57. Wan M, Leavens KF, Saleh D, Easton RM, Guertin DA, Peterson TR, et al. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab 2011;14:516-527.
58. Hussain MM, Shi J, Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 2003;44:22-32.
59. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. J Clin Invest 2008;118:2347-2364.